Our CA peptides product line includes high purity GLP-1 (1-37) and Tirzepatide (LY3298176), specifically developed for research applications. These peptides demonstrate exceptional quality with purity levels exceeding 99%, making them ideal for scientific investigations.
Tirzepatide (LY3298176) represents an innovative dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This CA peptides formulation has shown superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The CA peptides we produce maintain strict pharmaceutical grade standards. Our GLP-1 (1-37) peptide exhibits remarkable stability when stored properly, with a shelf life exceeding two years under recommended conditions.
For researchers requiring consistent, high-quality CA peptides, our manufacturing process ensures batch-to-batch reproducibility. The white powder formulation allows for convenient handling and preparation of research solutions.
Our CA peptides undergo rigorous quality control testing, including HPLC analysis, to verify purity and confirm molecular identity. This commitment to quality makes our products reliable for critical research applications.